Login / Signup
Xiao-Li Zhu
(Xiaoli Zhu)
ORCID
Publication Activity (10 Years)
Years Active: 2021-2024
Publications (10 Years): 3
Top Topics
Pulmonary Artery
Poor Prognosis
Signaling Pathway
Small Cell Lung Cancer
Top Venues
Canadian respiratory journal
Evidence-based complementary and alternative medicine : eCAM
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Li-Le Wang
,
Lu Xu
,
Shu-Hua Han
,
Xiao-Li Zhu
Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt Pathway.
Canadian respiratory journal
2024 (2024)
Li-Le Wang
,
Lu Xu
,
Shu-Hua Han
,
Xiao-Li Zhu
Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt Pathway.
Canadian respiratory journal
2024 (2024)
Li-Le Wang
,
Xiao-Li Zhu
,
Shu-Hua Han
,
Lu Xu
Hypoxia Upregulates NOTCH3 Signaling Pathway to Promote Endothelial-Mesenchymal Transition in Pulmonary Artery Endothelial Cells.
Evidence-based complementary and alternative medicine : eCAM
2021 (2021)